Your browser doesn't support javascript.
loading
Frequent Telomerase Reverse Transcriptase Promoter and Fibroblast Growth Factor Receptor 3 Mutations Support the Precursor Nature of Papillary Urothelial Hyperplasia of the Urinary Bladder.
Cheng, Liang; Lopez-Beltran, Antonio; Wang, Mingsheng; Whaley, Rumeal D; De Souza, Andre; Au, Sammy; Ge, Rongbin; Cimadamore, Alessia; Amin, Ali; Golijanin, Borivoj; MacLennan, Gregory T; Osunkoya, Adeboye O; Montironi, Rodolfo; Zhang, Shaobo.
Afiliação
  • Cheng L; Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Lifespan Academic Medical Center, and the Legorreta Cancer Center at Brown University, Providence, Rhode Island; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Ind
  • Lopez-Beltran A; Department of Morphological Sciences, University of Cordoba Medical School, Cordoba, Spain.
  • Wang M; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
  • Whaley RD; Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota.
  • De Souza A; Division of Hematology Oncology, Legorreta Cancer Center at Brown University, Lifespan Cancer Institute, Providence, Rhode Island.
  • Au S; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
  • Ge R; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, St Louis, Missouri.
  • Cimadamore A; Institute of Pathological Anatomy, University of Udine, Udine, Italy.
  • Amin A; Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Lifespan Academic Medical Center, and the Legorreta Cancer Center at Brown University, Providence, Rhode Island.
  • Golijanin B; Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Lifespan Academic Medical Center, and the Legorreta Cancer Center at Brown University, Providence, Rhode Island.
  • MacLennan GT; Department of Pathology and Urology, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
  • Osunkoya AO; Departments of Pathology and Urology, Emory University School of Medicine, Atlanta, Georgia.
  • Montironi R; Molecular Medicine and Cell Therapy Foundation, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, Italy.
  • Zhang S; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
Mod Pathol ; 36(7): 100151, 2023 07.
Article em En | MEDLINE | ID: mdl-36906071
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Telomerase Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Mod Pathol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Telomerase Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Mod Pathol Ano de publicação: 2023 Tipo de documento: Article